-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D0bA9bdfVWUWJUnpPekpLlq93jP7S8Qf6Zf9Gg7U1lJsYsFT4XRQwkwyzAG87IGU 4HpS8h9ZN70F3eEm1mV5Lw== 0001209191-08-014047.txt : 20080228 0001209191-08-014047.hdr.sgml : 20080228 20080228161745 ACCESSION NUMBER: 0001209191-08-014047 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080218 FILED AS OF DATE: 20080228 DATE AS OF CHANGE: 20080228 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESKEW MICHAEL L CENTRAL INDEX KEY: 0001227734 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 08650849 BUSINESS ADDRESS: STREET 1: UPS INVESTOR RELATIONS STREET 2: 55 GLENLAKE PKWY NE CITY: ATLANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 4048287232 3 1 doc3.xml FORM 3 SUBMISSION X0202 3 2008-02-18 1 0000059478 LILLY ELI & CO LLY 0001227734 ESKEW MICHAEL L LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 1 0 0 0 Michael L. Eskew 2008-02-28 EX-24.3_228142 2 poa.txt POA DOCUMENT Michael L. Eskew Lilly Corporate Center Indianapolis, Indiana 46285 Securities and Exchange Commission Washington, D.C. 20549 Authorization Regarding Reporting Forms I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder: Robert A. Armitage, Lilly Corporate Center, Indianapolis, Indiana James B. Lootens, Lilly Corporate Center, Indianapolis, Indiana Bronwen L. Mantlo, Lilly Corporate Center, Indianapolis, Indiana This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission. Michael L. Eskew February 28, 2008 -----END PRIVACY-ENHANCED MESSAGE-----